Related Experiment Videos

Hyperuricaemia in cyanotic congenital heart disease

Y Hayabuchi1, S Matsuoka, H Akita

  • 1Department of Paediatrics, University of Tukoshima School of Medicine, Japan.

Insights

Hyperuricaemia in cyanotic congenital heart disease (CCHD) is linked to polycythaemia severity and age. In infants, it stems from overproduction and reduced excretion; in older patients, impaired excretion is the primary cause.

Area of Science:

  • Cardiology
  • Nephrology
  • Biochemistry

Background:

  • Cyanotic congenital heart disease (CCHD) is associated with hyperuricaemia.
  • Factors contributing to elevated uric acid levels in CCHD patients require further elucidation.

Purpose of the Study:

  • To investigate the exacerbating factors of hyperuricaemia in patients with CCHD.
  • To differentiate the aetiology of hyperuricaemia based on age groups within the CCHD population.

Main Methods:

  • Cross-sectional study of 59 CCHD patients (1 month-30 years).
  • Assessment of serum uric acid, red blood cell count, hemoglobin, hematocrit, partial oxygen pressure, and arterial oxygen saturation.
  • Measurement of uric acid excretion and renal function in a subgroup of 10 hyperuricaemic patients.

Main Results:

  • Serum uric acid levels significantly correlated with patient age and polycythaemia severity.
  • No significant correlation was found between serum uric acid levels and oxygenation parameters (partial oxygen pressure, arterial oxygen saturation).
  • Infants showed normal 24-hour urinary uric acid excretion, while patients over 15 years exhibited markedly lower excretion.

Conclusions:

  • In infants with CCHD, hyperuricaemia appears to result from a combination of uric acid overproduction and diminished excretion.
  • In adolescents and adults with CCHD, hyperuricaemia is primarily attributed to age-related impairment of uric acid excretion.
  • Age and polycythaemia severity are key factors in hyperuricaemia development in CCHD.

Related Concept Videos